The Sacroiliac Joint - Ralph Rashbaum, MD

The Sacroiliac Joint - Patient Presentation and Achieving a Diagnosis
Ralph F. Rashbaum, MD shares his experience with the diagnosis and treatment of the SI joint.
Disclosures - Dr. Rashbaum is a paid SI-BONE consultant and a member of SI-BONE's Surgeon Advisory Board
All patient data presented were from patients treated for sacroiliac joint disruptions or degenerative sacroiliitis.
The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months.
There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks
U.S. Patent Nos. 8,202,305; 8,840,623; 8,986,348; and 9,039,743; pending U.S. and foreign patent applications.
©2013 SI-BONE, Inc. SI-BONE and iFuse Implant System are registered trademarks of SI-BONE, Inc. 8553.111513